The Eloquest Healthcare AVA Scholarship supports clinicians in attending the Association for Vascular Access Annual Scientific Meeting. Four recipients will be selected based on their commitment to advancing vascular access excellence. Prizes valued at $2500. Tell Me More.
Eloquest Healthcare News
Eloquest Healthcare is Offering Scholarships for those Interested in Attending AVA 2025 Annual Scientific Meeting
Interrad Medical’s SecurAcath is Superior to Standard of Care in Newly Published Randomized Controlled Clinical Study
Excellent results of a clinical study titled, “Securement to prevent non-cuffed central venous catheter dislodgement in pediatrics The SECURED superiority randomized clinical trial,” have recently been published. Read More.
Eloquest Healthcare is proud to be Certified™ by Great Place To Work® for the 7th year in a row.
The prestigious award is based entirely on what current employees say about their experience working at Eloquest. This year, 100% of employees said it’s a great place To Work – 43 points higher than the average U.S. company. Read more.
New Study Shows Major Benefits of Using Subcutaneous Anchor Securement Systems to Secure Central Vascular Access Devices
Vascular access expert Michelle Hawes, DNP, RN, CRNI, VA-BC, will present the results of a large retrospective study on PICC securement at the upcoming 2023 Annual Scientific Meeting of the Association for Vascular Access, according to Eloquest Healthcare, Inc., a privately held medical device company. Read more.
Eloquest Healthcare Joins APIC to Support International Infection Prevention Week
Eloquest Healthcare is proud to sponsor the Association for Professionals in Infection Control and Epidemiology public service campaign, International Infection Prevention Week, which aims to raise awareness about the importance of infection prevention and the essential role infection preventionists (IPs) play in public health and will take place October 16-22. Read More.
New study adds to evidence on best CVAD securement methodology
A new study on securement for central vascular access devices (CVAD) suggests that subcutaneous anchor securement systems (SASS) are shown to be more effective at keeping central catheters in place, compared to either suture-based or adhesive device-based securement methods. Read More.
New research from Dignity Health on improving quality of life for LVAD patients
A study at Dignity Health Mercy General Hospital showed that use of a special liquid adhesive to increase the durability of driveline (DL) dressings can reduce the risk of infection and improve quality of life for heart failure patients with left ventricular assist devices (LVADs). Read more.
Eloquest Healthcare and Interrad Medical Partner to Expand U.S. Sales of SecurAcath
The partnership adds the revolutionary SecurAcath device to Eloquest Healthcare’s existing clinically oriented product offering. Read more.
Eloquest Healthcare Announces New 5-year Agreement with Vizient GPO
Eloquest Healthcare is excited to announce new, 5-year MedSurg agreement with group purchasing organization Vizient Supply, LLC that will include Mastisol® Liquid Adhesive, Detachol® Adhesive Remover and ReliaTect® Post-Op Dressing with CHG. Under the new agreement, Vizient members can take advantage of special pricing for these products.